Literature DB >> 7852555

Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods.

J Tankovic1, P Legrand, G De Gatines, V Chemineau, C Brun-Buisson, J Duval.   

Abstract

During a 13-month period, 31 patients hospitalized primarily in two intensive care units (ICUs) were either colonized or infected by imipenem-resistant Acinetobacter baumannii. Typing of the isolates by three methods (antibiotyping, biotyping, and pulsed-field gel electrophoresis) revealed that two distinct strains were involved in the first 9 cases of the outbreak and that one of these strains, which had acquired a higher level of imipenem resistance as well as resistance to all aminoglycosides, accounted for 21 of 22 cases in the second part of the outbreak. ICU environmental contamination was recognized as an important reservoir of this epidemic strain. The outbreak ceased only after the ICUs were closed for complete cleaning and disinfection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7852555      PMCID: PMC264141          DOI: 10.1128/jcm.32.11.2677-2681.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  [Epidemiology of Acinetobacter and resistance to antibiotics at hospitals. A 5-year evaluation].

Authors:  M L Joly-Guillou; E Bergogne-Berezin; J F Vieu
Journal:  Presse Med       Date:  1990-03-03       Impact factor: 1.228

2.  Use of low-frequency-cleavage restriction endonucleases for DNA analysis in epidemiological investigations of nosocomial bacterial infections.

Authors:  A Allardet-Servent; N Bouziges; M J Carles-Nurit; G Bourg; A Gouby; M Ramuz
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

3.  Methicillin-resistant Staphylococcus aureus from China characterized by digestion of total DNA with restriction enzymes.

Authors:  L M Hall; J Z Jordens; F Wang
Journal:  Epidemiol Infect       Date:  1989-08       Impact factor: 2.451

4.  Delineation of new proteolytic genomic species in the genus Acinetobacter.

Authors:  P J Bouvet; S Jeanjean
Journal:  Res Microbiol       Date:  1989 May-Jun       Impact factor: 3.992

5.  Species, biotype, and bacteriophage type determinations compared with cell envelope protein profiles for typing Acinetobacter strains.

Authors:  P J Bouvet; S Jeanjean; J F Vieu; L Dijkshoorn
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

6.  Acinetobacter baumannii serotyping for delineation of outbreaks of nosocomial cross-infection.

Authors:  W H Traub
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

7.  Identification and biotyping of clinical isolates of Acinetobacter.

Authors:  P J Bouvet; P A Grimont
Journal:  Ann Inst Pasteur Microbiol       Date:  1987 Sep-Oct

8.  Laboratory investigation of hospital outbreak caused by two different multiresistant Acinetobacter calcoaceticus subsp. anitratus strains.

Authors:  J Vila; M Almela; M T Jimenez de Anta
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

9.  A study of the relationships between antibiotic resistance phenotypes, phage-typing and biotyping of 117 clinical isolates of Acinetobacter spp.

Authors:  M L Joly-Guillou; E Bergogne-Berezin; J F Vieu
Journal:  J Hosp Infect       Date:  1990-07       Impact factor: 3.926

10.  An outbreak of Acinetobacter respiratory tract infection resulting from incomplete disinfection of ventilatory equipment.

Authors:  C Cefai; J Richards; F K Gould; P McPeake
Journal:  J Hosp Infect       Date:  1990-02       Impact factor: 3.926

View more
  36 in total

1.  Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.

Authors:  Jian Li; Craig R Rayner; Roger L Nation; Roxanne J Owen; Denis Spelman; Kar Eng Tan; Lisa Liolios
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 2.  Acinetobacter species as nosocomial pathogens.

Authors:  D H Forster; F D Daschner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-02       Impact factor: 3.267

Review 3.  Hospital cleaning in the 21st century.

Authors:  S J Dancer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-17       Impact factor: 3.267

4.  Use of parenteral colistin for the treatment of multiresistant Gram-negative organisms in major burn patients in South Korea.

Authors:  Y S Cho; H Yim; H T Yang; J Hur; W Chun; J H Kim; B C Lee; D K Seo; J M Park; D Kim
Journal:  Infection       Date:  2011-09-06       Impact factor: 3.553

Review 5.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

6.  Acinetobacter spp as Nosocomial Pathogen : Clinical Significance and Antimicrobial Sensitivity.

Authors:  K K Lahiri; N S Mani; S S Purai
Journal:  Med J Armed Forces India       Date:  2011-07-21

7.  Isolation and identification of a Paenibacillus polymyxa strain that coproduces a novel lantibiotic and polymyxin.

Authors:  Zengguo He; Duygu Kisla; Liwen Zhang; Chunhua Yuan; Kari B Green-Church; Ahmed E Yousef
Journal:  Appl Environ Microbiol       Date:  2006-10-27       Impact factor: 4.792

8.  Carbapenem resistance mediated by beta-lactamases in clinical isolates of Acinetobacter baumannii in Spain.

Authors:  S López-Hernández; T Alarcón; M López-Brea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

9.  The molecular epidemiological study of colistin-only-sensitive strains in multi-drug resistant Acinetobacter baumannii.

Authors:  Li Yang; Lizhong Han; Jingyong Sun; Yunsong Yu; Yuxing Ni
Journal:  Front Med China       Date:  2007-10

10.  Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan.

Authors:  Po-Ren Hsueh; Lee-Jene Teng; Cheng-Yi Chen; Wen-Hwei Chen; Chong-Jen Yu; Shen-Wu Ho; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.